Drug affordability legislation gets second pass through Michigan Senate
Sen. Darrin Camilleri (D-Trenton), lead sponsor of a bill package that would create a Prescription Drug Affordability Board, speaking in support of the original legislation in 2023. | Kyle Davidson
For the second time, Michigan Senate Democrats have pushed forward legislation they say will bring to heel 'skyrocketing' prescription drug costs in the state.
On Thursday, the state Senate passed bills that would create a Prescription Drug Affordability Board, or PDAB, which would have the authority to set upper payment limits on drugs sold in Michigan.
'This board is a simple concept and a great idea,' Sen. Darrin Camilleri (D-Brownstown Township), sponsor of one of the bills, said. 'It allows for a public body of officials appointed by the governor, including folks who have no connection to the pharmaceutical industry whatsoever, who would then review some of these exorbitant price increases that we see from some companies as they are attempting to gouge the American consumer. They will hold them accountable. It will be a public and transparent process, and they will find ways to lower those costs for our residents.'
Republican opposition, however, centered on concerns of replacing a free market system with a 'government-controlled collectivist system,' as Sen. Thomas Albert (R-Lowell) referred to it.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
'Why do we have such a disproportionate amount of innovation and pharmaceuticals in the United States of America as opposed to the rest of the globe?' he asked. 'It's because the producers are free to innovate and they are free to have the market regulate the supply and the demand of the product. If you eliminate that, there's no incentive for innovation or entrepreneurship. It goes away. The competition is destroyed. This does not benefit people. This hurts people.'
The package, consisting of Senate Bills 3, 4 and 5, passed with a bare majority of 20 votes, with Sen. John DaMoose (R-Harbor Springs) the lone Republican to join the 19 Democrats in approval. The legislation now moves to the GOP-controlled House, where its future is less assured.
This is the second time Democrats have passed the bills through the Senate, with the upper chamber previously approving the legislation in October 2023, only to see it ultimately die without a vote in the House Insurance and Financial Services Committee. At the time, the House was controlled by Democrats, but with Republicans now in the majority there, passage will be even more difficult.
One ray of hope for supporters came from Damoose, who voted against the plan when it originally passed, but on Thursday said further investigation produced a change of heart on his part.
'Last term I was persuaded by the idea that the market should determine the cost of drugs,' Damoose said. 'But the more I learned, the more apparent it became that calling the prescription drug market a free market is a total farce. We are so far from being a free market when it comes to pharmaceuticals, it's unbelievable.'
Damoose noted the hundreds of billions of dollars invested by the federal government in developing many of the most popular and useful drugs, and yet U.S. taxpayers in many cases did not have affordable access to those drugs.
'It's unconscionable in my mind that those within the nation that supported the development of production of the most incredible body of medical advancement the world has ever seen would pay more than anyone else to access the benefits of those very prescription drugs,' Damoose said.
The pharmaceutical industry, however, sees the situation differently, with trade group PhRMA saying the proposed board would have 'long-term, harmful effects' on both the development of livesaving drugs and patients' ability to access them.
'Prescription Drug Affordability Boards are a disaster for patients,' said Stami Turk, director of public affairs at PhRMA. 'These bills put the government between patients and their doctors. Patients deserve access to the medicine their doctors prescribe – not roadblocks from Lansing. The House has the chance to do the right thing and to get the government out from in between patients and their physicians.'
Doctors, meanwhile, have welcomed the proposal, with support from the Michigan State Medical Society and the Committee to Protect Health Care.
Dr. Rob Davidson, is an emergency room physician in west Michigan and executive director of the committee.
'Doctors are encouraged to see this legislation to help our patients better afford their prescription drugs, and to help finally hold Big Pharma accountable, move forward in the legislative process,' Davidson said. 'We look forward to swift passage of these bills in both the Senate and House in Michigan so that our patients here can also benefit from upper payment limits and be able to take their medications as doctors like us prescribe.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Trump's ‘Big Beautiful Bill' Would Slash Medicaid & SNAP: 3 Moves Retirees Should Make Now
President Donald Trump's 'one big beautiful bill' has passed in the House and is now awaiting Senate approval. If passed, Trump's signature bill would extend the tax cuts granted by the 2017 Tax Cuts and Jobs Act and add additional tax cuts. While this might be welcome news to many, the bill also includes changes to Medicaid and the Supplemental Nutrition Assistance Program (SNAP) that could threaten seniors' access to these programs. Find Out: Read Next: 'The 'one big beautiful bill' passed by the House of Representatives, if it were passed into law today, would cut Medicaid and SNAP by a combined $1 trillion,' said Chris Orestis, president of Retirement Genius. 'In addition, because of the increase to federal debt of as much as $5 trillion, the bill would trigger an automatic reduction in Medicare funding of $500 billion,' he continued. 'This would represent the largest cut to social services and health insurance for the poor, disabled, children and the elderly in U.S. history.' Here's a look at the changes retirees can make now to secure care and avoid benefit disruptions if the bill were to pass. Before changes go into effect, check with your healthcare providers to ensure there won't be any interruption to your care if there are cuts to Medicaid. 'Check with your healthcare provider to see if they might cut back on services or cease accepting Medicaid-funded patients, and contact any nursing home where you or a loved one may reside to find out if they will be reducing the number of patients they can support — or even [if they are] possibly planning to close,' Orestis said. Knowing this ahead of time will allow you to find alternative care providers before it's too late. Learn More: If you are reliant on SNAP, start searching for alternatives that may be able to provide food assistance in the event your benefits are reduced or cut. 'Make sure you know where there are local support services through community or faith-based organizations to replace lost access through SNAP,' Orestis said. Many retirees plan to 'spend down' their savings so that they qualify for Medicaid to pay for their long-term care. However, this may no longer be a viable option. 'If you are considering going onto Medicaid for long-term care and are preparing to engage the 'spend down' process to impoverish yourself and get below the poverty level to qualify, you may want to reconsider that strategy, and instead look to leverage private pay resources to pay for your care,' Orestis said. 'If you are on Medicaid, you will primarily be reliant on nursing homes for your care, and their ability to withstand these cuts will be very challenging and up in the air,' he continued. 'If you are private pay, you are in control and can decide where and when you will receive care, such as at home or an assisted living community not funded by Medicaid.' Strategies to stay private pay for long-term care would include long-term care insurance, annuities, a life insurance settlement, a reverse mortgage or VA benefits. Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on More From GOBankingRates Clever Ways To Save Money That Actually Work in 2025 This article originally appeared on Trump's 'Big Beautiful Bill' Would Slash Medicaid & SNAP: 3 Moves Retirees Should Make Now
Wall Street Journal
an hour ago
- Wall Street Journal
GOP Senators' Competing Demands Risk Pulling Trump Megabill Apart
WASHINGTON—Senate Majority Leader John Thune (R., S.D.) is trying to release this week a revised version of President Trump's 'big, beautiful bill.' But as he races to pass the legislation ahead of Republicans' self-imposed July 4 deadline, he has got about as many problems as there are GOP senators, with lawmakers battling over the additional borrowing and spending cuts that will be used to finance tax relief, plus spending on the border and military.
Hamilton Spectator
an hour ago
- Hamilton Spectator
New crime novels feature a locked-room mystery, a Scarborough stabbing and a Jan. 6 insurrectionist
It's a weird time in American politics, which means it's a perfect time for Florida novelist Carl Hiaasen to plumb the satirical depths of corruption and malfeasance in his home state. His last novel, 2020's 'Squeeze Me,' suffered from a subplot that attempted to satirize the once-and-current occupant of the White House, a Falstaffian spray-tanned figure so outrageous as to be almost impervious to satire. For 'Fever Beach,' Hiaasen wisely steers clear of POTUS and his inept administration, preferring instead to focus on wanton corruption at a lower level. 'Fever Beach,' by Carl Hiaasen, Alfred A. Knopf, $34.99. The new novel begins with a meet-cute on an airplane between Twilly Spree and Viva Morales. Twilly is a stock Hiaasen character: an independently wealthy Florida do-gooder who spends his time making life miserable for folks who litter, antagonize the local wildlife or otherwise cause environmental or social havoc. Viva's job is administering the foundation of a couple of rich right-wing octogenarians whose fundraising operates as a money-laundering front to finance the campaign of far-right (and profoundly stupid) congressman Clure Boyette, in hot water with his obstreperous father over a scandal involving an underage prostitute named Galaxy. Add in Viva's landlord — a Jan. 6 insurrectionist named Dale Figgo who heads the Strokers for Freedom (a white nationalist militia whose name is a rebuke to the Proud Boys' insistence on refraining from masturbation) — and his cohort, the violent and reckless Jonas Onus, and you have all the ingredients for a classic Hiaasen caper. Twenty years ago, German-born author Leonie Swann debuted one of the most delightful detective teams in genre history: a flock of sheep on the trail of the person responsible for killing their shepherd with a spade through the chest. After a two-decade absence, Miss Maple, Othello, Mopple the Whale, and the other woolly sleuths are back on the case, this time on behalf of their new herder, Rebecca, the daughter of the early book's victim. 'Big Bad Wool,' by Leonie Swann, Soho Crime, $38.95. Rebecca, her intrusive Mum, and the sheep are overwintering in the lee of a French chateau where there are rumours of a marauding Garou — a werewolf — that is responsible for mutilating deer in the nearby woods. Among other strange occurrences, Rebecca's red clothing is found torn to pieces and some sheep go missing — and soon enough there's a dead human for the flock, in the uncomfortable company of a group of local goats, to deal with. 'Big Bad Wool' is a charming romp, whose pleasure comes largely from the ironic distance between the sheep's understanding of the world and that of the people who surround them. ('The humans in the stories did plenty of ridiculous things. Spring cleaning, revenge and diets.') Their enthusiasm and excitement results in prose that is a bit too reliant on exclamation points, and some of the more heavy-handed puns (like the sheep's insistence on 'woolpower') seem forced, but this is nevertheless a fun variation on the traditional country cosy. Romance novelist Uzma Jalaluddin takes a turn into mystery with this new book about amateur sleuth Kausar Khan. A widow in her late 50s, Kausar returns to Toronto from North Bay to help her daughter, Sana, who has been accused of stabbing her landlord to death in her Scarborough mall boutique. The police — including Sana's old flame, Ilyas — are convinced Sana is the prime suspect, but Kausar is determined to prove her daughter innocent. 'Detective Aunty,' by Uzma Jalaluddin, HarperCollins, $25.99. Her investigation involves a couple of competing developers, both of whom want to purchase the land on which the mall stands, along with members of the dead man's family and fellow shopkeepers. On the domestic front, Kausar finds herself concerned with Sana's deteriorating marriage to her husband, Hamza, and her teenage granddaughter's sullenness and mysterious nighttime disappearances. Jalaluddin does a good job integrating the various elements of her plot, and the familial relationships are nicely calibrated. The momentum is impeded, however, by a preponderance of clichés ('Playing devil's advocate, Kausar asked …'; 'Kausar's blood ran cold') and a tendency to hold the reader's hand by defining every easily Googleable Urdu word or greeting too programmatically. More attention to the writing on the line level would have helped move this one along. Yukito Ayatsuji's clever postmodern locked-room mystery was first published in Japanese in 2009; it appears for the first time in English translation, which is good news for genre fans. 'The Labyrinth House Murders,' by Yukito Ayatsuji, Pushkin Vertigo, $24.95. Ayatsuji's narrative is framed by Shimada, a mystery aficionado, who is presented with a novelization about murders that took place at the home of famed mystery writer Miyagaki Yotaro, found dead by his own hand soon after the manuscript opens. Miyagaki has left a bizarre challenge for the writers gathered at his Byzantine Labyrinth House: each must write a story featuring a murder, and the victim must be the writer him- or herself. The winning author, as adjudicated by a group of critics also convened at Labyrinth House, will inherit Miyagaki's sizable fortune. As the writers compete for the reward, bodies start falling in real life and Ayatsuji has a grand time playing metafictional games with his readers, challenging them to figure out who the culprit is in the context of a story that owes more than a small debt to Agatha Christie's 'And Then There Were None.' But Ayatsuji does Christie one better; it is only once the afterword, which closes the framed narrative, has unfolded that the reader fully understands how cleverly the author has conceived his multi-layered fictional trap.
